Integral Diagnostics Akcie

Integral Diagnostics EBITDA

EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) společnosti Integral Diagnostics (IDX.AX) k datu 12. 8. 2026 je 114,83 Mil. AUD. V předchozím roce byl EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) 89,03 Mil. AUD — změna o 28,97 % (vyšší).

EBITDA

114,83 Mil.AUD

YoY

28,97%

Poslední aktualizace:

EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) společnosti Integral Diagnostics je 2026 114,83 Mil. AUD. EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) společnosti Integral Diagnostics byl 2025 89,03 Mil. AUD. Klesá tak o 28,97% vyšší než v předchozím roce.
Access this data via the Eulerpool API

Integral Diagnostics Analýza akcií

Co dělá Integral Diagnostics? Integral Diagnostics Ltd is an Australian company that has been providing medical imaging services for over 25 years. The company was founded in 1994 by Dr. Ian Kadish and a team of radiologists in Perth, Western Australia, offering radiology services to local clinics and hospitals. Over the years, Integral Diagnostics has expanded its services to provide imaging services nationwide. The business model of Integral Diagnostics is to deliver medical imaging to enable doctors and their patients to have a fast and accurate diagnosis. The company offers imaging services for a variety of medical specialties, including radiology, cardiology, obstetrics and gynecology, and neurology. They operate over 49 locations in Australia, many of which are in rural areas where access to medical care may be limited. Integral Diagnostics offers a wide range of products based on medical imaging. These include X-rays, mammography, ultrasound, CT scans, MRI scans, PET scans, and bone density scans. The company takes pride in being one of the few Australian medical imaging companies to offer a complete range of imaging services. Their services are conducted by qualified radiologists specialized in interpreting medical images. Integral Diagnostics also operates clinics for performing diagnostic and therapeutic procedures such as biopsies, drainages, and injections. These procedures are carried out by highly qualified radiologists to provide patients with faster and more accurate diagnoses. Integral Diagnostics is committed to quality assurance and has a comprehensive quality management system that is annually reviewed by independent auditors. The company is accredited by both the Australian Medical Association and the Australian National Accreditation Scheme (NATA). These accreditations recognize the high standards that Integral Diagnostics sets for delivering medical imaging services. One of Integral Diagnostics' recent activities is their use of artificial intelligence (AI) in image interpretation. The company has partnered with MaxQ AI, a leading provider of AI solutions for medical imaging. Through this partnership, Integral Diagnostics doctors can utilize the latest AI tools to improve their patients' diagnoses. Integral Diagnostics is a strong advocate for social justice and is dedicated to supporting disadvantaged communities in Australia. The company has partnered with nonprofit organizations such as the National Breast Cancer Foundation, The Smith Family, and the Friendship Foundation. Overall, Integral Diagnostics has undergone impressive growth over the past 25 years and is now a leading Australian medical imaging company. With a wide range of imaging services and a strong focus on quality and social responsibility, the company is well-positioned to continue its success in the future. Integral Diagnostics je jednou z nejoblíbenějších společností na Eulerpool.com.

Často kladené otázky ohledně akcií Integral Diagnostics

EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) společnosti Integral Diagnostics činí 114,83 Mil. AUD v roce 2026.

EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) společnosti Integral Diagnostics se změnilo z 89,03 Mil. AUD na 114,83 Mil. AUD, což představuje změnu o 28,97 %. Hodnota je vyšší než v předchozím roce.

Na Eulerpool najdete úplný historický vývoj EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) Integral Diagnostics od roku 2006 – s ročními hodnotami, grafy a podrobnou analýzou.

EBITDA měří operační výkonnost před dopadem finanční struktury, daňového prostředí a bezhotovostních odpisů.

EBITDA = EBIT + Odpisy

AUD společnosti EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) je důležitým faktorem pro investory. Změny v tomto ukazateli mohou signalizovat zlepšování nebo zhoršování fundamentů, což může ovlivnit cenu akcie. Na Eulerpool můžete sledovat Integral Diagnostics společnosti EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) historicky.

Access this data via the Eulerpool API

Výkaz zisku a ztráty — Integral Diagnostics

Všechny klíčové ukazatele — Integral Diagnostics